Profil bibliographique

Aranzazu Jauregui-Amezaga

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

66Publications signalées

1774Citations signalées

2Affiliations récentes

Institutions déclarées

University of Antwerp Antwerp University Hospital

Domaines associés

Inflammatory Bowel DiseaseMicroscopic ColitisAutoimmune and Inflammatory DisordersGastrointestinal Bleeding Diagnosis and TreatmentColorectal Cancer Screening and Detection

Publications récentes

2026 articleOpenAlex

Effect of JAK inhibitors on extraintestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease

Marie Truyens, Xenia Tolstoy, Giulio Calabrese, Anneline Cremer et autres

0 citationsJournal of Crohn s and Colitis

2026 conference-abstractOpenAlex

P0574 Impact of proactive medical prophylactic management versus a reactive approach on long-term disease recurrence after ileocecal resection for Crohn’s disease. Results of an exploratory extension of the PORCSE study

Jeroen Geldof, M Truyens, Emily Van Gucht, Konstantinos Argyriou et autres

0 citationsJournal of Crohn s and Colitis

Accès ouvert 2026 articleOpenAlex

P0069 Mucin RNA Isoform Expression and Its Association with Clinical Severity Scores and Barrier Gene Networks in Ulcerative Colitis

Baptiste Oosterlinck, Julie Gassman, Aranzazu Jauregui-Amezaga, M Somers et autres

0 citationsJournal of Crohn s and Colitis

2026 conference-abstractOpenAlex

P0780 Effect of JAK inhibitors on extra-intestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease

M Truyens, X Tolstoy, Giuseppe Calabrese, Paola Balestrieri et autres

0 citationsJournal of Crohn s and Colitis

Accès ouvert 2026 articleOpenAlex

P0814 Effect of IL-23 inhibitors on extra-intestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease

M Truyens, X Tolstoy, G Calabrese, Paola Balestrieri et autres

0 citationsJournal of Crohn s and Colitis

2026 conference-abstractOpenAlex

P1157 Willingness to switch from optimized intravenous to subcutaneous infliximab in IBD: baseline characteristics from the AMARETTO trial

A Moens, T Holvoet, J Guedelha Sabino, P Bossuyt et autres

0 citationsJournal of Crohn s and Colitis

Accès ouvert 2025 reviewOpenAlex

Clinical Significance of Mucin Signatures in Inflammatory Bowel Diseases: A Systematic Review of Their Expression Patterns, Polymorphisms, and Post-translational Modifications

Wout Arras, Baptiste Oosterlinck, Julie Gassman, Joris G. De Man et autres

3 citationsInflammatory Bowel Diseases

Accès ouvert 2025 articleOpenAlex

The EXTENT Study: Results From an International Expert Delphi Consensus to Define Ultrasonographic Parameters for Measuring Bowel Damage in Crohn’s Disease

Carolina Palmela, Joana Torres, C Frias Gomes, Mariangela Allocca et autres

3 citationsClinical Gastroenterology and Hepatology

2025 conference-abstractOpenAlex

Mo1857: THE EXTENT STUDY (CALCULATING THE LEMANN INDEX USING INTESTINAL ULTRASOUND): RESULTS FROM AN INTERNATIONAL EXPERT DELPHI CONSENSUS

Carolina Palmela, Joana Torres, C Frias Gomes, Mariangela Allocca et autres

0 citationsGastroenterology

2025 conference-abstractOpenAlex

Su1876: PRELIMINARY RESULTS ON EXPECTATIONS AND SATISFACTION OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB IN PATIENTS PREVIOUSLY TREATED WITH AN OPTIMIZED INTRAVENOUS INFLIXIMAB DOSING SCHEDULE.

Tom Holvoet, Annick Moens, Peter Bossuyt, Triana Lobatón et autres

0 citationsGastroenterology

Accès ouvert 2025 conference-abstractOpenAlex

P1008 Subcutaneous infliximab in IBD patients previously treated with an optimized intravenous infliximab dosing schedule: preliminary results on expectations and satisfaction of switching from intravenous to subcutaneous infliximab

Annick Moens, Tom Holvoet, Patrick M. Bossuyt, Triana Lobatón et autres

1 citationJournal of Crohn s and Colitis

2025 conference-abstractOpenAlex

P0477 Perianal Crohn’s fistula in the absence of luminal disease -natural history, time to progression to luminal disease and management in contemporary clinical practice: An ECCO-CONFER case series

K Basnayake, Tim Raine, David Drobne, O M Nardone et autres

0 citationsJournal of Crohn s and Colitis

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.